These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25973046)

  • 1. CD317 is over-expressed in B-cell chronic lymphocytic leukemia, but not B-cell acute lymphoblastic leukemia.
    Gong S; Osei ES; Kaplan D; Chen YH; Meyerson H
    Int J Clin Exp Pathol; 2015; 8(2):1613-21. PubMed ID: 25973046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia.
    Babusíková O; Zelezníková T; Mlcáková A; Kusenda J; Stevulová L
    Neoplasma; 2005; 52(6):502-9. PubMed ID: 16284697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometry.
    Muzzafar T; Medeiros LJ; Wang SA; Brahmandam A; Thomas DA; Jorgensen JL
    Am J Clin Pathol; 2009 Nov; 132(5):692-8. PubMed ID: 19846809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen Expression on Blast Cells and Hematological Parameters at Presentation in Acute Lymphoblastic Leukemia Patients.
    Naeem S; Bukhari MH
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):407-11. PubMed ID: 26100991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia.
    Veltroni M; De Zen L; Sanzari MC; Maglia O; Dworzak MN; Ratei R; Biondi A; Basso G; Gaipa G;
    Haematologica; 2003 Nov; 88(11):1245-52. PubMed ID: 14607753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia.
    Seegmiller AC; Kroft SH; Karandikar NJ; McKenna RW
    Am J Clin Pathol; 2009 Dec; 132(6):940-9. PubMed ID: 19926587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
    Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD200 in High-Grade Lymphoma, Chronic Lymphocytic Leukemia, and Chronic Lymphocytic Leukemia-Phenotype Monoclonal B-Cell Lymphocytosis.
    Sorigue M; Junca J; Granada I
    Am J Clin Pathol; 2015 Oct; 144(4):677-9. PubMed ID: 26386092
    [No Abstract]   [Full Text] [Related]  

  • 10. The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: how different are they from their normal counterparts?
    Sędek Ł; Bulsa J; Sonsala A; Twardoch M; Wieczorek M; Malinowska I; Derwich K; Niedźwiecki M; Sobol-Milejska G; Kowalczyk JR; Mazur B; Szczepański T
    Cytometry B Clin Cytom; 2014 Sep; 86(5):329-39. PubMed ID: 24845957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROR1 is expressed on hematogones (non-neoplastic human B-lymphocyte precursors) and a minority of precursor-B acute lymphoblastic leukemia.
    Broome HE; Rassenti LZ; Wang HY; Meyer LM; Kipps TJ
    Leuk Res; 2011 Oct; 35(10):1390-4. PubMed ID: 21813176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia.
    Sędek Ł; Theunissen P; Sobral da Costa E; van der Sluijs-Gelling A; Mejstrikova E; Gaipa G; Sonsala A; Twardoch M; Oliveira E; Novakova M; Buracchi C; van Dongen JJM; Orfao A; van der Velden VHJ; Szczepański T;
    J Immunol Methods; 2019 Dec; 475():112429. PubMed ID: 29530508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
    Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.
    Eksioğlu-Demiralp E; Alpdoğan O; Aktan M; Firatli T; Oztürk A; Budak T; Bayik M; Akoğlu T
    Leukemia; 1996 Aug; 10(8):1331-9. PubMed ID: 8709639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZAP-70 is highly expressed in most cases of childhood pre-B cell acute lymphoblastic leukemia.
    Wandroo F; Bell A; Darbyshire P; Pratt G; Stankovic T; Gordon J; Lawson S; Moss P
    Int J Lab Hematol; 2008 Apr; 30(2):149-57. PubMed ID: 18333847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of CD123 in lymphocytic leukemia and its significance for monitoring minimal residual diseases.].
    Wang YF; Chen BG; Luo WD; Zheng R; Li BL
    Zhonghua Xue Ye Xue Za Zhi; 2010 Apr; 31(4):244-8. PubMed ID: 20510041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZAP-70 expression is low in normal precursor B cells or hematogones.
    Davis BH; Schwartz M
    Cytometry B Clin Cytom; 2006 Jul; 70(4):315-9. PubMed ID: 16906572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD71 by flow cytometry in acute leukemias: More often seen in acute myeloid leukemia.
    Pande A; Dorwal P; Jain D; Tyagi N; Mehra S; Sachdev R; Raina V
    Indian J Pathol Microbiol; 2016; 59(3):310-3. PubMed ID: 27510666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?
    Erikci AA; Karagoz B; Ozyurt M; Ozturk A; Kilic S; Bilgi O
    Hematology; 2009 Apr; 14(2):101-5. PubMed ID: 19298722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.